A Phase II Trial of Pancreaticoduodenectomy Plus Postoperative Cisplatin, Interferon Alfa-2b, and 5-FU Combined With Radiation Treatment for Patients With Resected Pancreatic Adenocarcinoma.

Trial Profile

A Phase II Trial of Pancreaticoduodenectomy Plus Postoperative Cisplatin, Interferon Alfa-2b, and 5-FU Combined With Radiation Treatment for Patients With Resected Pancreatic Adenocarcinoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Feb 2012

At a glance

  • Drugs Cisplatin; Fluorouracil; Interferon alpha-2b
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Feb 2012 Actual initiation date changed from 1 May 2003 to 1 May 2002 as reported by ClinicalTrials.gov.
    • 14 Feb 2012 Actual initiation date changed from 1 May 2003 to 1 May 2002 as reported by ClinicalTrials.gov.
    • 14 Feb 2012 Actual patient number (29) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top